• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Savara, Inc. - Common Stock (NQ:SVRA)

    5.265 +0.005 (+0.10%)
    Streaming Delayed Price Updated: 11:19 AM EDT, Sep 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Savara, Inc. - Common Stock

    < Previous 1 2 Next >
    Top movers in Tuesday's after hours session ↗
    Via Chartmill
    News headline image
    What Savara Investors Should Know About This 580,187-Option Exercise and FDA Timeline ↗
    This clinical-stage biotech focused on rare lung diseases reported significant insider selling amid a year of strong share gains. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge ↗
    This biotech firm develops therapies for urothelial cancers, leveraging proprietary delivery technology and a growing clinical pipeline. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    SVRA Stock Earnings: Savara Misses EPS for Q2 2024 ↗
    SVRA stock results show that Savara missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    News headline image
    SVRA Stock Earnings: Savara Misses EPS for Q1 2024 ↗
    SVRA stock results show that Savara missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    News headline image
    SVRA Stock Earnings: Savara Beats EPS for Q4 2023 ↗
    SVRA stock results show that Savara beat analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    News headline image
    Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally ↗
    Vir Biotechnology develops immunology-based therapies targeting infectious diseases through global partnerships and scientific innovation. 
    Via The Motley Fool
    News headline image
    VR Adviser Adds Over 1 Million Savara Shares ↗
    This clinical-stage biotech develops inhaled therapies for rare respiratory diseases, with its lead candidate in Phase III trials. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    SVRA Stock Rises After Hours As FDA Grants Priority Review For Lung Disorder Therapy ↗
    The company is seeking approval for Molbreevi to treat patients with Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP). 
    Via Stocktwits
    Topics Intellectual Property Lawsuit
    Get insights into the top gainers and losers of Friday's after-hours session. ↗
    Via Chartmill
    What's going on in today's pre-market session ↗
    Via Chartmill
    News headline image
    This Starbucks Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗
     
    Via Benzinga
    News headline image
    Why Is Rare Lung Disease-Focused Savara Stock Trading Lower On Tuesday? ↗
    Savara's Molbreevi BLA for autoimmune PAP was rejected by the FDA due to incomplete CMC data; the company plans to resubmit in Q4 2025. 
    Via Benzinga
    News headline image
    Here are the top movers in Tuesday's session. ↗
    Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
    Via Chartmill
    News headline image
    Dow Surges Over 600 Points; US Durable Goods Orders Fall in April ↗
     
    Via Benzinga
    Topics Stocks
    News headline image
    There are notable gap-ups and gap-downs in today's session. ↗
    In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down. 
    Via Chartmill
    News headline image
    Nasdaq Jumps Over 300 Points On EU Tariff Delay; AutoZone Posts Downbeat Earnings ↗
     
    Via Benzinga
    News headline image
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    Why Is Respiratory Disease-Focused Savara Stock Trading Higher On Wednesday? ↗
    Savara announces Phase 3 IMPALA-2 trial results for molgramostim in treating autoimmune pulmonary alveolar proteinosis. The inhaled GM-CSF met primary and secondary endpoints, showing significant... 
    Via Benzinga
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
    It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning! 
    Via InvestorPlace
    News headline image
    3 Penny Stocks Poised for Major Upside Over the Next 5 Years ↗
    These three penny stocks to buy are poised for major upside over the medium-term, for various reasons worth exploring. 
    Via InvestorPlace
    News headline image
    3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition ↗
    Don’t miss out on these three penny stocks, which have amazing potential to take off following upcoming business developments this year. 
    Via InvestorPlace
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday ↗
    U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday. 
    Via Benzinga
    Topics Stocks
    News headline image
    5 OTC Stocks With The Potential To Explode In 2024 ↗
    Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from and available investing platforms. 
    Via Benzinga
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.